drugset / Trial / NCT00123266
Intra-arterial Microplasmin Administration in Patients With Acute Intracranial Vertebrobasilar Artery Occlusion
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of the trial is to evaluate the safety of microplasmin as well as its ability to open blocked arteries to the brain in patients with acute stroke when given into the artery at the site of the blockage.
Timeline
- Start
- 2006-12
- Primary completion
- 2007-07
- Completion
- 2008-08
Outcome
Outcome not reported
Stopped: “Sponsor's decision not to pursue development of uPLi for vascular conditions.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ocriplasmin | Protein / enzyme biologic | 2 mg/kg | Other |